TMO
Thermo Fisher Scientific Inc.
$524.71
+14.58 (+2.86%)
At close · Jul 9
Market Cap
$195.48B
Shares
371,621,465
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-26 | 2026-05-20 | |
| 10-Q | 2026-05-01 | 2026-03-28 | |
| 8-K | 2026-04-23 | — | |
| DEF 14A | 2026-04-07 | 2026-05-20 | |
| 8-K | 2026-03-24 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-12 | 2026-02-09 | |
| 8-K | 2026-01-29 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-01 | 2025-11-24 | |
| 10-Q | 2025-10-31 | 2025-09-27 | |
| 8-K | 2025-10-29 | — | |
| 8-K | 2025-10-22 | — | |
| 8-K | 2025-10-07 | — | |
| 8-K | 2025-09-02 | 2025-09-01 | |
| 10-Q | 2025-08-01 | 2025-06-28 | |
| 8-K | 2025-07-23 | — | |
| 8-K | 2025-07-23 | — | |
| 8-K | 2025-05-28 | 2025-05-21 | |
| 8-K | 2025-05-22 | 2025-05-21 | |
| 10-Q | 2025-05-02 | 2025-03-29 | |
| 8-K | 2025-04-23 | — | |
| DEF 14A | 2025-04-08 | 2025-05-21 | |
| 8-K | 2025-02-25 | — | |
| 10-K | 2025-02-20 | 2024-12-31 | |
| 8-K | 2025-02-19 | — | |
| 8-K | 2025-01-30 | — | |
| 10-Q | 2024-11-01 | 2024-09-28 | |
| 8-K | 2024-10-23 | — | |
| 10-Q | 2024-08-02 | 2024-06-29 | |
| 8-K | 2024-07-24 | — | |
| 8-K | 2024-07-10 | — | |
| 8-K | 2024-05-24 | 2024-05-22 | |
| 10-Q | 2024-05-03 | 2024-03-30 | |
| 8-K | 2024-04-24 | — | |
| DEF 14A | 2024-04-09 | 2024-05-22 | |
| 10-K | 2024-02-22 | 2023-12-31 | |
| 8-K | 2024-01-31 | — | |
| 8-K | 2023-12-05 | — | |
| 8-K | 2023-11-07 | — | |
| 10-Q | 2023-11-03 | 2023-09-30 | |
| 8-K | 2023-10-25 | — | |
| 8-K | 2023-10-17 | — | |
| 8-K/A | 2023-09-21 | 2023-07-13 | |
| 8-K | 2023-08-10 | — | |
| 8-K | 2023-08-08 | — | |
| 10-Q | 2023-08-04 | 2023-07-01 | |
| 8-K | 2023-07-26 | — | |
| 8-K | 2023-07-13 | — | |
| 8-K | 2023-05-26 | 2023-05-24 |
Showing 1–50 of 123 filings
Key facts
CIK
97745
CUSIP
883556102
13F (30d)
234 filings
155 filers
Visit website
Investor relations